Title
A comparative cross-cultural study of the prevalence of late life depression in low and middle income countries
Date Issued
15 January 2016
Access level
open access
Resource Type
journal article
Author(s)
Prina A.M.
Ferri C.P.
Acosta D.
Gallardo S.
Huang Y.
Jacob K.S.
Jimenez-Velazquez I.Z.
Llibre Rodriguez J.J.
Liu Z.
Salas A.
Sosa A.L.
Williams J.D.
Uwakwe R.
Prince M.
Publisher(s)
Elsevier B.V.
Abstract
Background Current estimates of the prevalence of depression in later life mostly arise from studies carried out in Europe, North America and Asia. In this study we aimed to measure the prevalence of depression using a standardised method in a number of low and middle income countries (LMIC). Methods A one-phase cross-sectional survey involving over 17,000 participants aged 65 years and over living in urban and rural catchment areas in 13 sites from 9 countries (Cuba, Dominican Republic, Puerto Rico, Mexico, Venezuela, Peru, China, India and Nigeria). Depression was assessed and compared using ICD-10 and EURO-D criteria. Results Depression prevalence varied across sites according to diagnostic criteria. The lowest prevalence was observed for ICD-10 depressive episode (0.3 to 13.8%). When using the EURO-D depression scale, the prevalence was higher and ranged from 1.0% to 38.6%. The crude prevalence was particularly high in the Dominican Republic and in rural India. ICD-10 depression was also associated with increased age and being female. Limitations Generalisability of findings outside of catchment areas is difficult to assess. Conclusions Late life depression is burdensome, and common in LMIC. However its prevalence varies from culture to culture; its diagnosis poses a significant challenge and requires proper recognition of its expression.
Start page
362
End page
368
Volume
190
Language
English
OCDE Knowledge area
Psicología
Neurociencias
Subjects
Scopus EID
2-s2.0-84946227601
PubMed ID
Source
Journal of Affective Disorders
ISSN of the container
01650327
Sponsor(s)
The 10/66 Dementia Research Group population based surveys were supported by the Wellcome Trust (UK) ( GR066133 ); the World Health Organization ; the US Alzheimer’s Association ( IIRG – 04–1286 ); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). Matthew Prina is funded by the Medical Research Council [Grant number= MR/K021907/1 ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Sources of information:
Directorio de Producción Científica
Scopus